Bayer Aktiengesellschaft (FRA:BAYA)
6.70
+0.05 (0.75%)
At close: Oct 23, 2025
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 10.74B EUR in the quarter ending June 30, 2025, a decrease of -3.63%. This brings the company's revenue in the last twelve months to 46.17B, down -1.99% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
46.17B
Revenue Growth
-1.99%
P/S Ratio
0.59
Revenue / Employee
515.59K
Employees
91,864
Market Cap
27.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
| Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
| Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
| Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
| Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 139.36B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Siemens Aktiengesellschaft | 78.30B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Siemens Energy AG | 38.39B |
| SAP SE | 36.49B |
| Deutsche Bank Aktiengesellschaft | 30.07B |
Bayer Aktiengesellschaft News
- 2 days ago - Top 3 Health Care Stocks You'll Regret Missing In October - Benzinga
- 2 days ago - Bayer Leverkusen vs PSG: Head-to-head, match preview, predicted lineups and score prediction - Business Upturn
- 14 days ago - BAYRY Begins Phase I Study With KQB548 in KRAS-Mutated Cancers - Nasdaq
- 14 days ago - Why Bayer's Worst Years Might Be The Start Of Its Comeback - Seeking Alpha
- 15 days ago - 3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal - Nasdaq
- 16 days ago - Hesperos and Bayer Consumer Health Develop First Human-on-a-Chip® Model of Stress-Induced Cognitive Dysfunction - Business Wire
- 16 days ago - Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest - Business Wire
- 16 days ago - One A Day® Unveils Bold New Brand Identity and Platform: "The ONE for you" - Benzinga